eFFECTOR Therapeutics, Inc. (EFTR)
(Delayed Data from NSDQ)
$1.60 USD
-0.10 (-5.88%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -1.74 |
EPS Last Quarter | -2.16 |
Last EPS Surprise | 0.46% |
ABR | 1.00 |
Earnings ESP
|
-16.43% |
---|---|
Current Year | -5.63 |
Next Year | -2.25 |
EPS (TTM) | -13.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 3.55M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.74 | -1.54 | -5.63 | -2.25 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -1.45 | -1.12 | -5.08 | NA |
High Estimate | -1.45 | -1.12 | -5.08 | -2.25 |
Low Estimate | -2.02 | -1.95 | -6.17 | -2.25 |
Year ago EPS | -4.25 | -3.25 | -16.37 | -5.63 |
Year over Year Growth Est. | 59.06% | 52.62% | 65.61% | 59.95% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.74 | -1.54 | -5.63 | -2.25 |
7 Days Ago | -1.74 | -1.54 | -5.63 | -2.25 |
30 Days Ago | -1.68 | -1.29 | -5.18 | -2.03 |
60 Days Ago | -1.68 | -0.85 | -4.46 | -2.92 |
90 Days Ago | -1.59 | -1.03 | -4.92 | -3.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.02 | -1.95 | -6.17 | -2.25 |
Zacks Consensus Estimate | -1.74 | -1.54 | -5.63 | -2.25 |
Earnings ESP | -16.43% | -27.04% | -9.69% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.16 | -3.42 | -3.25 | -4.25 | NA |
Estimate | -2.17 | -2.73 | -3.25 | -4.75 | NA |
Difference | 0.01 | -0.69 | 0.00 | 0.50 | -0.05 |
Surprise | 0.46% | -25.27% | 0.00% | 10.53% | -3.57% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more